Zobrazeno 1 - 10
of 103
pro vyhledávání: '"C. H. W. Horne"'
Autor:
Julie Gray, Mark Rees, Ian Marshall, Ian D. Milton, Kenneth Mitchell, Mik Pinkney, Gary McIntosh, C. H. W. Horne, Nigel H. Piggott
Publikováno v:
Hybridoma and Hybridomics. 23:11-18
Recently, several antibodies have allowed the detection of estrogen receptor beta (ER-beta) in paraffin-embedded tissue; however, these attempts have failed to specifically identify the wild-type form and revealed technical difficulties such as the n
Publikováno v:
British Journal of Cancer
Topoisomerases are nuclear enzymes that modulate the topological structure of DNA in order to facilitate cellular events such as replication and transcription. These enzymes are also the cellular targets of certain classes of chemotherapeutic agents
Autor:
P. Watson, Nigel H. Piggott, I. D. Milton, C. H. W. Horne, S. Smith, Stephen J. Proctor, Brian Angus, A. Lodge, H Bell, G. G. Mcintosh, Penelope R. A. Taylor, John Anderson, M Steward, Katrina M Wood, F. Jack
Publikováno v:
Histopathology. 36:145-150
Aims Assessment of the expression of antigens CD5, CD10 and CD23 can be of value in the differential diagnosis of small B-cell lymphoma. Correct subclassification is important since optimal treatment regimes differ between the subtypes. The aim of th
Autor:
John Anderson, Brian Angus, Andrew G. Hall, A J Lodge, Gary McIntosh, M Steward, Michael M. Reid, C. H. W. Horne
Publikováno v:
The Journal of Pathology. 186:A1-A35
Autor:
Bruce R. Westley, Nigel Piggot, T. W. J. Lennard, Michael J. Carter, C. H. W. Horne, Brian Angus, Geoffrey L. Toms, Linda Henry, Ian D. Milton, Debra J. Bevitt
Publikováno v:
The Journal of Pathology. 183:228-232
Assessment of oestrogen and progesterone receptors (ER and PgR) in breast cancer is widely used for the prediction of response to endocrine therapy and as a prognostic marker. Cytosolic assays have been replaced in many centres by immunochemical tech
Autor:
Brian Angus, M. K. Cook, A. Heppleston, Adrian L. Harris, R. C. F. Leonard, J. T. Roberts, Angela Dawson, Robin J Prescott, Anne Lennard, R. G. B. Evans, S. J. Proctor, H Lucraft, P Dawes, J. B. Macgillivray, A. M. Lessells, A. S. Krajewski, W. D. Thompson, M. J. Galloway, A. C. Parker, David Cameron, J. M. White, C. H. W. Horne, Paul Taylor, M. J. Mackie
Publikováno v:
European Journal of Cancer. 33:1195-1201
The aim of this study was to test whether survival for patients with high-grade non-Hodgkin's lymphoma (NHL) can be improved with a non-cross-resistant regimen as compared to a CHOP-based regimen. This is a multicentre study comprising 325 adult pati
Autor:
Gary McIntosh, C. H. W. Horne, John Anderson, M. D. Thomas, D. M. Mckenna, R. Johnstone, T. W. J. Lennard, A. H. Parr, Brian Angus
Publikováno v:
Journal of Clinical Pathology. 50:143-147
AIM: To develop a highly sensitive and specific enzyme linked immunosorbent assay (ELISA) system for analysis of p53 protein in cancer lysates. METHODS: The anti-p53 monoclonal antibodies DO7, 1801, BP53.12, and 421, and anti-p53 polyclonal antiserum
Publikováno v:
Histopathology. 30:16-22
Phenotypic analysis of lymphoproliferative disorders is now considered mandatory for accurate classification which is the basis for optimum patient management. This is presently carried out in most cases using a range of antibodies recognizing B and
Autor:
Myles D. Thomas, Dina Tiniakos, Glenda M. Horne, Thomas W. J. Lennard, John Anderson, Pernille Autzen, C. H. W. Horne, J. A. Henry, Gary G. McINTOSH, Brian Angus, J B Reed
Publikováno v:
The Journal of Pathology. 180:65-70
Cyclic phosphorylation/dephosphorylation of the retinoblastoma gene product (pRB) has been found to play a central role in the progression of the normal cell cycle, through modulation of the activity of the E2F family of transcription factors. Mutati
Autor:
H. Greenwood, C. H. W. Horne, K. B. Robinson, A. I. M. Cook, P. Cullen, B. Angus, Dina Tiniakos
Publikováno v:
Cytopathology. 7:178-186
The aim of this study was to co-evaluate c-erb B-2 and p53 protein expression in breast cancer fine needle aspirates (FNA) and to compare this with histological variables and the immunohistochemical phenotype of the tumours. Furthermore, we assessed